首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性阻塞性肺疾病急性加重期痰浊阻肺型应用陈汤加味治疗的临床疗效研究
引用本文:陈诗源,吕建兴.慢性阻塞性肺疾病急性加重期痰浊阻肺型应用陈汤加味治疗的临床疗效研究[J].中医临床研究,2014(13):9-11.
作者姓名:陈诗源  吕建兴
作者单位:海丰县彭湃纪念医院;
摘    要:目的:探究慢性阻塞性肺疾病急性加重期痰浊阻肺型应用陈汤加味治疗的临床疗效研究。方法:资料随机选自2010年5月-2013年5月在本院诊治的慢性阻塞性肺疾病急性加重期痰浊阻肺型患者80例,将患者按照随机数字表方法分成两组,每组40例,予以常规西医治疗作对照组,予以常规治疗基础上进行陈汤加味治疗作研究组,分析两组的临床疗效、肺功能指数及不良反应情况。结果:经不同方案治疗后,研究组总的有效率95.00%,比对照组总的有效率77.50%高,比较差异具统计学意义(P〈0.05);研究组肺功能的相关指标均比对照组优,比较差异具统计学意义(P〈0.05);研究组不良反应的发生率5.00%,比对照组不良反应的发生率17.50%低,比较差异具统计学意义(P〈0.05)。结论:对于慢性阻塞性肺疾病急性加重期痰浊阻肺型患者,予以陈汤加味进行治疗,成效显著,且不良反应发生较少,具有一定临床应用价值。

关 键 词:慢性阻塞性肺疾病  急性加重期  痰浊阻肺型  陈汤加味

Clinical effective on treating chronic obstructive pulmonary disease with Chen decoction
Abstract:Objective: To investigate the clinical efficacy of Chen decoction for chronic obstructive pulmonary disease. Methods: 80 patients with chronic obstructive pulmonary disease were divided into two groups, each of 40 cases, conventional western medicine as a control group, more Chen decoction than conventional as treatment group. Results: In the study group overall efficiency of 95.00%, higher than the total efficiency of 77.50% in the control group, there was a statistically significance difference (P〈0.05); relevant indicators of lung function in the study group, better than that in control group, there was a statistically significant difference (P〈0.05); adverse reaction incidence 5.00% in the study group was lower than 17.50% in the control group (P〈0.05). Conclusion: Chronic obstructive pulmonary disease can be treated with Chen decoction, with remarkable results and fewer adverse reactions.
Keywords:Chronic obstructive pulmonary disease  Acute exacerbation  Phlegm obstructing lung type  Chen docoction
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号